Guillermo Saurina is an Infectious Disease physician. OpenAlex indexes 13 publications with 1,054 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2301 N Ashley St
Valdosta, GA 316022620
Telephone
229-245-0666Registry record last updated 7 Mar 2011.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ViiV Healthcare CompanyProgram year20213 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
57.5%Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor19.3%Triumeq55%Emtricitabine-Tenofovir Disop33%Zidovudine12%Part D<11 patientsHuman Immunodeficiency Virus Integrase Strand Transfer Inhibitor6.8%Tivicay67%Isentress33%Part D<11 patients+ 10 more classes in this area
Cardiovascular
14.5%Calcium channel blocker3.8%Amlodipine Besylate100%Part D<11 patientsBeta blocker3.8%Metoprolol Succinate52%Carvedilol48%Part D<11 patients+ 3 more classes in this area
Metabolism & gastrointestinal
9.3%Proton pump inhibitor3.7%Omeprazole50%Pantoprazole Sodium50%Part D<11 patientsPotassium supplement3.7%Potassium Chloride100%Part D≥11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Antimicrobial resistance in Enterobacteriaceae in Brooklyn, NY: epidemiology and relation to antibiotic usage patterns
Journal of Antimicrobial Chemotherapy
2000 - Vancomycin-Resistant Enterococci in Brooklyn, New York: A Moment in Time
Clinical Infectious Diseases
1999 - Cure of Metronidazole- and Tinidazole-Resistant Trichomoiasis with Use of High-Dose Oral and Intravaginal Tinidazole
Clinical Infectious Diseases
1998 - Failure of All Antifungal Therapy for Infection Due to<i>Candida albicans</i>. A New AIDS‐Related Problem?
Clinical Infectious Diseases
1998
Similar KOLs
Other experts from the same institution or the same specialty.
Yousef Khader
Jordan University of Science and Technology
Andrew Rambaut
University of Edinburgh
Olayinka Stephen Ilesanmi
University College Hospital
Maysaa El Sayed Zaki
Mansoura University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”